Showing results (161-170 of 254) with videos related to
Sort By:
Pageof 26
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2020
Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based ApproachKemal Caglar Gogebakan, Elizabeth G Berry, Alan C Geller, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate CancerJeanette K Birnbaum, Ziding Feng, Roman Gulati, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2025
Sensitivity Measures in Studies of Cancer Early Detection BiomarkersYibai Zhao, Roman Gulati, Jane Lange, et al.JAMA|April 7, 2024
Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-AnalysisXiaoshuang Feng, Hana Zahed, Justina Onwuka, et al.American Journal of Preventive Medicine|December 20, 2011
Biopsy follow-up of prostate-specific antigen testsSteven B Zeliadt, Diana S M Buist, Robert J Reid, et al.Journal of the National Cancer Institute|March 2, 2011
Influence of publication of US and European prostate cancer screening trials on PSA testing practicesSteven B Zeliadt, Richard M Hoffman, Ruth Etzioni, et al.Journal of the National Cancer Institute|March 12, 2009
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and contextGerrit Draisma, Ruth Etzioni, Alex Tsodikov, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2021
Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United StatesBoshen Jiao, Roman Gulati, Nathaniel Hendrix, et al.JCO Clinical Cancer Informatics|August 19, 2024
Prostate-Specific Antigen Screening and Prostate Cancer Mortality: An Emulation of Target Trials in US MedicareXabier García-Albéniz, John Hsu, Ruth Etzioni, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2002
Androgen receptor polymorphisms and the incidence of prostate cancerChu Chen, Najib Lamharzi, Noel S Weiss, et al.Pageof 26